Quarterly report · Q3

Period2023-04-01 → 2023-12-31
Filed2024-02-08
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 36
MetricValuePeriodScopeSource row
Revenue¥4.4bn2023-04-01 → 2023-12-31Cons.Net sales
Revenue¥5.2bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥3.9bn2022-04-01 → 2022-12-31Cons.Net sales
Operating income¥773m2023-04-01 → 2023-12-31Cons.Operating income
Operating income¥734m2022-04-01 → 2022-12-31Cons.Operating income
Ordinary income¥717m2023-04-01 → 2023-12-31Cons.Ordinary income
Ordinary income¥1.0bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥746m2022-04-01 → 2022-12-31Cons.Ordinary income
Profit before tax¥717m2023-04-01 → 2023-12-31Cons.Income before income taxes
Profit before tax¥640m2022-04-01 → 2022-12-31Cons.Income before income taxes
Net income (owners)¥461m2023-04-01 → 2023-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥574m2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥414m2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income¥461m2023-04-01 → 2023-12-31Cons.Profit loss
Net income¥414m2022-04-01 → 2022-12-31Cons.Profit loss
Total assets¥6.4bnat 2023-12-31Cons.Assets
Total assets¥5.8bnat 2023-03-31Cons.Assets
Total assets¥5.7bnat 2022-12-31Cons.Total assets (5-year summary)
Total liabilities¥2.0bnat 2023-12-31Cons.Liabilities
Total liabilities¥1.7bnat 2023-03-31Cons.Liabilities
Net assets / equity¥4.4bnat 2023-12-31Cons.Net assets
Net assets / equity¥4.1bnat 2023-03-31Cons.Net assets
Net assets / equity¥4.0bnat 2022-12-31Cons.Net assets (5-year summary)
Cash and deposits¥3.8bnat 2023-12-31Cons.Cash and deposits
Cash and deposits¥3.7bnat 2023-03-31Cons.Cash and deposits
EPS (basic)¥39.252023-04-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥13.682023-10-01 → 2023-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥48.682022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥35.052022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥6.472022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥38.552023-04-01 → 2023-12-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥47.572022-04-01 → 2023-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥34.22022-04-01 → 2022-12-31Cons.Diluted earnings per share (5-year summary)
Equity ratio68.5%at 2023-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio70.6%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio70.1%at 2022-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 43
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-04-01 → 2023-12-31¥600,000
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-04-01 → 2023-12-31¥600,000
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-04-01 → 2023-12-31¥300,000
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-12-31−¥28m
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-12-31−¥28m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-12-31−¥258m
jpcrp040300-q3r_E32408-000Globalreportable segmentrevenue2023-04-01 → 2023-12-31¥3.2bn
jpcrp040300-q3r_E32408-000Globalreportable segmentrevenue external2023-04-01 → 2023-12-31¥3.2bn
jpcrp040300-q3r_E32408-000Globalreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥26m
jpcrp040300-q3r_E32408-000Globalreportable segmentsegment profit2023-04-01 → 2023-12-31¥290m
jpcrp040300-q3r_E32408-000Medicalreportable segmentrevenue2023-04-01 → 2023-12-31¥1.2bn
jpcrp040300-q3r_E32408-000Medicalreportable segmentrevenue external2023-04-01 → 2023-12-31¥1.2bn
jpcrp040300-q3r_E32408-000Medicalreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥3m
jpcrp040300-q3r_E32408-000Medicalreportable segmentsegment profit2023-04-01 → 2023-12-31¥741m
—segment totalrevenue2023-04-01 → 2023-12-31¥4.4bn
—segment totalrevenue external2023-04-01 → 2023-12-31¥4.4bn
—segment totalrevenue intersegment2023-04-01 → 2023-12-31¥28m
—segment totalsegment profit2023-04-01 → 2023-12-31¥1.0bn
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-12-31¥4.4bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-12-31¥4.4bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2023-12-31¥28m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-12-31¥1.0bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-12-31¥300,000
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-12-31¥300,000
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-12-31¥150,000
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-12-31−¥33m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-12-31−¥33m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-12-31−¥240m
jpcrp040300-q3r_E32408-000Globalreportable segmentrevenue2022-04-01 → 2022-12-31¥2.8bn
jpcrp040300-q3r_E32408-000Globalreportable segmentrevenue external2022-04-01 → 2022-12-31¥2.8bn
jpcrp040300-q3r_E32408-000Globalreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥33m
jpcrp040300-q3r_E32408-000Globalreportable segmentsegment profit2022-04-01 → 2022-12-31¥312m
jpcrp040300-q3r_E32408-000Medicalreportable segmentrevenue2022-04-01 → 2022-12-31¥1.1bn
jpcrp040300-q3r_E32408-000Medicalreportable segmentrevenue external2022-04-01 → 2022-12-31¥1.1bn
jpcrp040300-q3r_E32408-000Medicalreportable segmentsegment profit2022-04-01 → 2022-12-31¥662m
—segment totalrevenue2022-04-01 → 2022-12-31¥3.9bn
—segment totalrevenue external2022-04-01 → 2022-12-31¥3.9bn
—segment totalrevenue intersegment2022-04-01 → 2022-12-31¥33m
—segment totalsegment profit2022-04-01 → 2022-12-31¥974m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-12-31¥3.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-12-31¥3.9bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-12-31¥33m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-12-31¥974m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 347
ItemContextValueUnit
Lease obligations nclPrior1YearInstant61872000JPY
Lease obligations nclCurrentQuarterInstant36959000JPY
Deferred tax liabilitiesPrior1YearInstant183528000JPY
Deferred tax liabilitiesCurrentQuarterInstant190378000JPY
Net defined benefit liabilityPrior1YearInstant108596000JPY
Net defined benefit liabilityCurrentQuarterInstant231523000JPY
Asset retirement obligations nclPrior1YearInstant16256000JPY
Asset retirement obligations nclCurrentQuarterInstant19095000JPY
Noncurrent liabilitiesPrior1YearInstant370253000JPY
Noncurrent liabilitiesCurrentQuarterInstant477955000JPY
LiabilitiesPrior1YearInstant1706809000JPY
LiabilitiesCurrentQuarterInstant2000662000JPY
Capital stockPrior1YearInstant799706000JPY
Capital stockCurrentQuarterInstant804615000JPY
Capital surplusPrior1YearInstant704322000JPY
Capital surplusCurrentQuarterInstant709231000JPY
Retained earningsPrior1YearInstant2737681000JPY
Retained earningsCurrentQuarterInstant3069900000JPY
Treasury stockPrior1YearInstant-295612000JPY
Treasury stockCurrentQuarterInstant-295612000JPY
Shareholders equityPrior1YearInstant3946098000JPY
Shareholders equityCurrentQuarterInstant4288135000JPY
Valuation difference on available for sale securitiesPrior1YearInstant71248000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant36060000JPY
Foreign currency translation adjustmentPrior1YearInstant128156000JPY
Foreign currency translation adjustmentCurrentQuarterInstant203897000JPY
Remeasurements of defined benefit plansPrior1YearInstant-55262000JPY
Remeasurements of defined benefit plansCurrentQuarterInstant-156599000JPY
Valuation and translation adjustmentsPrior1YearInstant144142000JPY
Valuation and translation adjustmentsCurrentQuarterInstant83358000JPY
Subscription rights to sharesPrior1YearInstant168000JPY
Subscription rights to sharesCurrentQuarterInstant13376000JPY
Net assetsPrior1YearInstant4090409000JPY
Net assetsCurrentQuarterInstant4384870000JPY
Liabilities and net assetsPrior1YearInstant5797219000JPY
Liabilities and net assetsCurrentQuarterInstant6385532000JPY
Net salesPrior1YTDDuration3910774000JPY
Net salesCurrentYTDDuration4397927000JPY
Cost of salesPrior1YTDDuration2391920000JPY
Cost of salesCurrentYTDDuration2741595000JPY
Gross profitPrior1YTDDuration1518853000JPY
Gross profitCurrentYTDDuration1656332000JPY
Selling general and administrative expensesPrior1YTDDuration784898000JPY
Selling general and administrative expensesCurrentYTDDuration883121000JPY
Operating incomePrior1YTDDuration733954000JPY
Operating incomeCurrentYTDDuration773211000JPY
Interest income noiPrior1YTDDuration861000JPY
Interest income noiCurrentYTDDuration3074000JPY
Equity in earnings of affiliates noiPrior1YTDDuration6126000JPY
Equity in earnings of affiliates noiCurrentYTDDuration3696000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass rounding
balance sheet identityconsolidated 2023-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2023-04-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass